The role of HCV proteins on treatment outcomes

For many years, the standard of treatment for hepatitis C virus (HCV) infection was a combination of pegylated interferon alpha (Peg-IFN-α) and ribavirin for 24–48 weeks. This treatment regimen results in a sustained virologic response (SVR) rate in about 50 % of cases. The failure of IFN-α-based th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumthip, Kattareeya, Maneekarn, Niwat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678629/
https://www.ncbi.nlm.nih.gov/pubmed/26666318
http://dx.doi.org/10.1186/s12985-015-0450-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678629/
https://www.ncbi.nlm.nih.gov/pubmed/26666318
http://dx.doi.org/10.1186/s12985-015-0450-x

Ejemplares similares